1-8 of 8
Justin Budka
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 867: Multi-omic characterization of tumor microenvironment evolution in LBCL across treatment lines: Insights from Atlas classification and axicabtagene ciloleucel trials

Michael D. Mattie, Regis Perbost, Aurelie Auguste, Alexia Papadopoulos, Jenny J. Kim, Ioana Kloos, Gayatri Tiwari, Justin Budka, Darawan Rinchai, Simone Filosto, Rhine Shen, Davide Bedognetti, Jérôme Galon
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 867.
https://doi.org/10.1158/1538-7445.AM2025-867
Published: 21 April 2025
View articletitled, Abstract 867: Multi-omic characterization of tumor microenvironment evolution in LBCL across treatment lines: Insights from Atlas classification and axicabtagene ciloleucel trials
Journal Articles

Abstract 3194: Opposing roles of product CD27 and TIGIT expression in outcome to CAR-T cell therapy in R/R LBCL

Justin Budka, Subing Cao, Chad Williams, Gabriela Balderrama-Gutierrez, Soumya Poddar, Mike Mattie, Jenny J. Kim, Saran Vardhanabhuti, Yohei Arihara, Yusuke Kamihara, Shogo Miura, Jerome Ritz, Davide Bedognetti, Simone Filosto
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 3194.
https://doi.org/10.1158/1538-7445.AM2025-3194
Published: 21 April 2025
View articletitled, Abstract 3194: Opposing roles of product CD27 and TIGIT expression in outcome to CAR-T cell therapy in R/R LBCL
Journal Articles

Abstract LB092: Novel tumor gene expression signatures predictive of outcome in large B cell lymphoma treated with CAR T cell therapy (axicabtagene ciloleucel)

Yuan Tian, Justin Budka, Frederick L. Locke, Jason R. Westin, Christina To, Shilpa Shahani, Davide Bedognetti, Rhine R. Shen, Jorge Andrade, Simone Filosto
Journal: Cancer Research
Cancer Res (2024) 84 (7_Supplement): LB092.
https://doi.org/10.1158/1538-7445.AM2024-LB092
Published: 05 April 2024
View articletitled, Abstract LB092: Novel tumor gene expression signatures predictive of outcome in large B cell lymphoma treated with CAR T cell therapy (axicabtagene ciloleucel)
Journal Articles

Abstract 37: IL-4 drives CART cell exhaustion in a CD4 independent manner

Carli M. Stewart, Elizabeth L. Siegler, Truc N. Huynh, R. Leo Sakemura, Brooke Kimball, Long Mai, Kun Yun, James H. Girsch, Jennifer Feigin, Omar Gutierrez Ruiz, Makena Rodriguez, Ekene Ogbodo, Ismail Can, Claudia Manriquez Roman, Olivia Sirpilla, Hong Xia, Jenny Kim, Justin Budka, Mike Mattie, Nathalie Scholler, Simone Filosto, Saad S. Kenderian
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 37.
https://doi.org/10.1158/1538-7445.AM2024-37
Published: 22 March 2024
View articletitled, Abstract 37: IL-4 drives CART cell exhaustion in a CD4 independent manner
Journal Articles

Abstract CT166: Pretreatment (PreTx) immune cell phenotypes in peripheral blood associated with the tumor immune contexture, product attributes, and durable clinical efficacy in patients with large B-cell lymphoma (LBCL) treated with axicabtagene ciloleucel (axi-cel)

Justin Budka, Justin Chou, Vicki Plaks, Francesca Milletti, Zixing Wang, Frederick L. Locke, Sattva S. Neelapu, David B. Miklos, Caron A. Jacobson, Lazaros J. Lekakis, Yi Lin, Armin Ghobadi, Zahid Bashir, Nathalie Scholler, Jérôme Galon, John M. Rossi, Adrian Bot
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): CT166.
https://doi.org/10.1158/1538-7445.AM2021-CT166
Published: 01 July 2021
View articletitled, Abstract CT166: Pretreatment (PreTx) immune cell phenotypes in peripheral blood associated with the tumor immune contexture, product attributes, and durable clinical efficacy in patients with large B-cell lymphoma (LBCL) treated with axicabtagene ciloleucel (axi-cel)
Journal Articles

Abstract 1611: Caloric restriction potentiates the therapeutic benefit of androgen deprivation therapy and alters macrophage polarization when combined with PD1 inhibition in murine models of prostate cancer

May Elbanna, Justin Budka, Paige Dausinas, Remi Adelaiye-Ogala, Nur Damayanti, Ashley Orillion, Eri Banno, Luigi Fontana, Roberto Pili
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 1611.
https://doi.org/10.1158/1538-7445.AM2019-1611
Published: 01 July 2019
View articletitled, Abstract 1611: Caloric restriction potentiates the therapeutic benefit of androgen deprivation therapy and alters macrophage polarization when combined with PD1 inhibition in murine models of prostate cancer
Journal Articles

Abstract 2366: HDAC inhibition improves immune checkpoint inhibitor efficacy in renal cell carcinoma

Justin Budka, Nur Damayanti, Roberto Pili
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 2366.
https://doi.org/10.1158/1538-7445.AM2019-2366
Published: 01 July 2019
View articletitled, Abstract 2366: HDAC inhibition improves immune checkpoint inhibitor efficacy in renal cell carcinoma
Journal Articles

EZH2 Modifies Sunitinib Resistance in Renal Cell Carcinoma by Kinome Reprogramming

Remi Adelaiye-Ogala, Justin Budka, Nur P. Damayanti, Justine Arrington, Mary Ferris, Chuan-Chih Hsu, Sreenivasulu Chintala, Ashley Orillion, Kiersten Marie Miles, Li Shen, May Elbanna, Eric Ciamporcero, Sreevani Arisa, Piergiorgio Pettazzoni, Giulio F. Draetta, Mukund Seshadri, Bradley Hancock, Milan Radovich, Janaiah Kota, Michael Buck, Heike Keilhack, Brian P. McCarthy, Scott A. Persohn, Paul R. Territo, Yong Zang, Joseph Irudayaraj, W. Andy Tao, Peter Hollenhorst, Roberto Pili
Journal: Cancer Research
Cancer Res (2017) 77 (23): 6651–6666.
https://doi.org/10.1158/0008-5472.CAN-17-0899
Published: 30 November 2017
View articletitled, EZH2 Modifies Sunitinib Resistance in Renal Cell Carcinoma by Kinome Reprogramming
Open the PDF for EZH2 Modifies Sunitinib Resistance in Renal Cell Carcinoma by Kinome Reprogramming in another window
Includes: Supplementary data